PMC Stock Overview
Engages in the production and distribution of pharmaceutical products for the Vietnamese community.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Pharmedic Pharmaceutical Medicinal Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫98,000.00 |
| 52 Week High | ₫100,000.00 |
| 52 Week Low | ₫66,000.00 |
| Beta | 0.35 |
| 11 Month Change | 11.36% |
| 3 Month Change | 20.99% |
| 1 Year Change | 40.20% |
| 33 Year Change | 47.37% |
| 5 Year Change | 61.72% |
| Change since IPO | 66.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMC | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 5.0% | -2.7% | -2.9% |
| 1Y | 40.2% | 11.6% | 2.1% |
Return vs Industry: PMC exceeded the VN Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: PMC exceeded the VN Market which returned 2.1% over the past year.
Price Volatility
| PMC volatility | |
|---|---|
| PMC Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.9% |
| 10% least volatile stocks in VN Market | 2.8% |
Stable Share Price: PMC has not had significant price volatility in the past 3 months.
Volatility Over Time: PMC's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 534 | Tran Trung | www.pharmedic.com.vn |
Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the production and distribution of pharmaceutical products for the Vietnamese community. The company offers over-the-counter medicinal products, hepatobiliary systems, cardiovascular systems, respiratory systems, central nervous systems, Musculo-skeletal systems, hormones, anti-infectives, Genito-urinary systems, endocrine and metabolic systems, and vitamins and minerals, as well as eyes, ears, nose and throat, and cough treatment products. It also provides dermatological products, allergy and immune system products, functional foods, medicines from medicinal herbs, antiseptic products, anti-allergy drugs, gastrointestinal drugs, analgesic and antipyretic products, anti-inflammatory and gout treatment products, cardiovascular and diabetes products, and neuropathy products.
Pharmedic Pharmaceutical Medicinal Joint Stock Company Fundamentals Summary
| PMC fundamental statistics | |
|---|---|
| Market cap | ₫914.59b |
| Earnings (TTM) | ₫61.78b |
| Revenue (TTM) | ₫516.74b |
14.8x
P/E Ratio1.8x
P/S RatioIs PMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMC income statement (TTM) | |
|---|---|
| Revenue | ₫516.74b |
| Cost of Revenue | ₫336.39b |
| Gross Profit | ₫180.34b |
| Other Expenses | ₫118.56b |
| Earnings | ₫61.78b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.62k |
| Gross Margin | 34.90% |
| Net Profit Margin | 11.96% |
| Debt/Equity Ratio | 0% |
How did PMC perform over the long term?
See historical performance and comparison